RareCyte is a precision biology solution focused on the multiplexed analysis of cells and tissue with applications in both research and clinical diagnostics.
www.rarecyte.com
Seattle, WA
CEO: Joe Victor
Arboretum Lead: Jan Garfinkle
RareCyte
IN THE NEWS
RareCyte® selected for the Wellcome Leap In Utero program
RareCyte Inc., ("RareCyte" or "The Company") a leading provider of Precision Biology products and services has been selected by Wellcome Leap to participate in the $50M In Utero program to create…
Read More
RareCyte® Secures $24M Financing to Advance the Orion™ Spatial Biology Platform
RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company developing and manufacturing proprietary platforms enabling precision biology solutions, announced today the completion of a $24M financing from new and…
Read More
